$Alvotech(ALVO)$ Take loss on -To The Moon - Tiger Brokers Online Investing Community - To The Moon

27
3
Favorite

CutieYolkYolk
11-03

$Alvotech(ALVO)$

Take loss on this trade. Earnings on Nov 12 but the bad news are already out.

The US FDA rejected its application for its arthritis drug and this had hit a snap on its pipeline.

Regardless of the company will recover or not, I'm trying to be a bit more disciplined in cutting losers.

Will see if my renewed commitment to cut loser will help to improving my overall portfolio performance or jeopardise it.

ALVO

11-03 23:02

USAlvotech

Side	Price \| Filled	Realized P&L
Sell Close	5.42 228	-38.93% Closed

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

27

Report

Comment（3）

Top
Latest

Trade Feed Decoder
·11-04
TOP
Analyzing the ALVO trade: The -38.93% realized loss highlights significant downside risk inherent in biotech stocks, which often face binary outcomes from clinical/regulatory developments. While specific trade rationale isn't provided, such steep losses suggest either adverse company news or broader sector pressures impacted the position. The sale at $5.42 reflects a decision to limit further downside, though timing relative to key catalysts (earnings, FDA decisions) remains unclear without valid date context. This trade underscores the volatility of pre-revenue biotech firms and the importance of position sizing in high-risk sectors. Investors might consider pairing speculative biotech positions with defined risk-management strategies given their event-driven nature.
Reply
Like
Report
Mortimer Arthur
·11-05
alvotech on the verge of breaking out... with 3 approvals near they might be able to hit $1 billion in revenue for 2026
Reply
Like
Report
Enid Bertha
·11-05
The market is giving up on this stock. Sad to see it happen, did not expect this to drop too 5 usd.

Reply
Like
Report

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":496270660042928,"tweetId":"496270660042928","gmtCreate":1762182364002,"gmtModify":1762275136388,"author":{"id":4165037565910622,"idStr":"4165037565910622","authorId":4165037565910622,"authorIdStr":"4165037565910622","name":"CutieYolkYolk","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.29","individualDisplayEnabled":0},"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.19","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":684,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":583,"starInvestorOrderShareNum":822,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":38.22,"showRor":true,"winRationPercentage":79.553903,"tradeVolumeEst":0},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/ALVO\">$Alvotech(ALVO)$&nbsp;</a><p>Take loss on this trade. Earnings on Nov 12 but the bad news are already out.&nbsp;</p>\n<p>The US FDA rejected its application for its arthritis drug and this had hit a snap on its pipeline.&nbsp;</p>\n<p>Regardless of the company will recover or not, I'm trying to be a bit more disciplined in cutting losers.&nbsp;</p>\n<p>Will see if my renewed commitment to cut loser will help to improving my overall portfolio performance or jeopardise it.</p></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/ALVO\">$Alvotech(ALVO)$&nbsp;</a><p>Take loss on this trade. Earnings on Nov 12 but the bad news are already out.&nbsp;</p>\n<p>The US FDA rejected its application for its arthritis drug and this had hit a snap on its pipeline.&nbsp;</p>\n<p>Regardless of the company will recover or not, I'm trying to be a bit more disciplined in cutting losers.&nbsp;</p>\n<p>Will see if my renewed commitment to cut loser will help to improving my overall portfolio performance or jeopardise it.</p></body></html>","text":"$Alvotech(ALVO)$ Take loss on this trade. Earnings on Nov 12 but the bad news are already out. The US FDA rejected its application for its arthritis drug and this had hit a snap on its pipeline. Regardless of the company will recover or not, I'm trying to be a bit more disciplined in cutting losers. Will see if my renewed commitment to cut loser will help to improving my overall portfolio performance or jeopardise it.","highlighted":1,"essential":1,"paper":1,"likeSize":27,"commentSize":3,"repostSize":1,"favoriteSize":0,"link":"https://ttm.financial/post/496270660042928","repostId":0,"isVote":1,"tweetType":1,"viewCount":1207,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ALVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4165037565910622","orderId":"41062620812938240","kind":"TRADE","symbol":"ALVO","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/ALVO\">$Alvotech(ALVO)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/ALVO","symbolName":"Alvotech","market":"US","action":"SELL","currency":"USD","symbolLogo":"","showFilledQuantity":true,"nameCN":"Alvotech","orderType":"LMT","filledQuantityFinal":228,"avgFillPrice":5.42,"createTime":1762182135,"filledQuantity":"228","filledQuantityScale":"0","openFlag":false,"side":"DEBIT","contractMajorDescription":"Alvotech","contractExtraDescription":"ALVO","legs":[],"completedFlag":true,"orderPnl":{"realizedPnlPercent":-0.3893,"realizedPnlByAveragePercent":-0.3893},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":331,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":496300137144896,"commentId":"496300137144896","gmtCreate":1762189528544,"gmtModify":1762189533301,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":496270660042928,"objectIdStr":"496270660042928","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Analyzing the ALVO trade: The -38.93% realized loss highlights significant downside risk inherent in biotech stocks, which often face binary outcomes from clinical/regulatory developments. While specific trade rationale isn't provided, such steep losses suggest either adverse company news or broader sector pressures impacted the position. The sale at $5.42 reflects a decision to limit further downside, though timing relative to key catalysts (earnings, FDA decisions) remains unclear without valid date context. This trade underscores the volatility of pre-revenue biotech firms and the importance of position sizing in high-risk sectors. Investors might consider pairing speculative biotech positions with defined risk-management strategies given their event-driven nature.","text":"Analyzing the ALVO trade: The -38.93% realized loss highlights significant downside risk inherent in biotech stocks, which often face binary outcomes from clinical/regulatory developments. While specific trade rationale isn't provided, such steep losses suggest either adverse company news or broader sector pressures impacted the position. The sale at $5.42 reflects a decision to limit further downside, though timing relative to key catalysts (earnings, FDA decisions) remains unclear without valid date context. This trade underscores the volatility of pre-revenue biotech firms and the importance of position sizing in high-risk sectors. Investors might consider pairing speculative biotech positions with defined risk-management strategies given their event-driven nature.","html":"Analyzing the ALVO trade: The -38.93% realized loss highlights significant downside risk inherent in biotech stocks, which often face binary outcomes from clinical/regulatory developments. While specific trade rationale isn't provided, such steep losses suggest either adverse company news or broader sector pressures impacted the position. The sale at $5.42 reflects a decision to limit further downside, though timing relative to key catalysts (earnings, FDA decisions) remains unclear without valid date context. This trade underscores the volatility of pre-revenue biotech firms and the importance of position sizing in high-risk sectors. Investors might consider pairing speculative biotech positions with defined risk-management strategies given their event-driven nature.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"},{"id":496966139904776,"commentId":"496966139904776","gmtCreate":1762349043436,"gmtModify":1762349532535,"authorId":10000000000010994,"author":{"id":10000000000010994,"idStr":"10000000000010994","authorId":10000000000010994,"name":"Mortimer Arthur","avatar":"https://static.tigerbbs.com/b8515044e6fcc500a9ce3ca05f33533b","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":496270660042928,"objectIdStr":"496270660042928","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"alvotech on the verge of breaking out...  with 3 approvals near they might be able to hit $1 billion in revenue for 2026  <br>","text":"alvotech on the verge of breaking out...  with 3 approvals near they might be able to hit $1 billion in revenue for 2026  <br>","html":"alvotech on the verge of breaking out...  with 3 approvals near they might be able to hit $1 billion in revenue for 2026  <br>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":496909501768456,"commentId":"496909501768456","gmtCreate":1762335215766,"gmtModify":1762335220620,"authorId":10000000000010992,"author":{"id":10000000000010992,"idStr":"10000000000010993","authorId":10000000000010992,"name":"Enid Bertha","avatar":"https://static.tigerbbs.com/a539edbf3388702a82cb1d4728704766","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":496270660042928,"objectIdStr":"496270660042928","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"The market is giving up on this stock. Sad to see it happen, did not expect this to drop too 5 usd.\n<br><br>","text":"The market is giving up on this stock. Sad to see it happen, did not expect this to drop too 5 usd.\n<br><br>","html":"The market is giving up on this stock. Sad to see it happen, did not expect this to drop too 5 usd.\n<br><br>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}